Status:
RECRUITING
Improving Pain Disability With the Use of Oral Cannabinoids
Lead Sponsor:
University Health Network, Toronto
Conditions:
Chronic Pain
Opioid Use
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
The investigators are conducting a pilot (i.e. a small study) in order to find out the effectiveness and safety of medical cannabis in the management of chronic pain. At the end of this 3 month study,...
Detailed Description
Chronic pain is defined as pain lasting longer than three months, affects \~20% of Canadian adults. In addition to having a significant negative impact at the individual patient level (i.e., decreased...
Eligibility Criteria
Inclusion
- Age ≥ 25 years
- Able to understand and read English
- Experiencing chronic, non-palliative pain
Exclusion
- Use of nabilone, nabiximols or cannabis in the 30 days preceding study recruitment
- Known allergy to cannabis or any cannabinoid
- Serious ongoing medical issues (i.e., lung, liver, kidney or heart disease) that in the opinion of the Investigator would compromise the safety of the patient
- Current uncontrolled serious mental disorders such as schizophrenia, or psychosis
- Currently pregnant or breast-feeding (a negative urine pregnancy test must be obtained for women of child bearing potential during pretreatment evaluation)
- Men and women planning to start a family in the next 12 weeks
- Has declared a current alcohol or substance use disorder (excluding opioid use disorder)
- Currently using Methadone or Buprenorphine
- Patients who are naïve to pain treatments
Key Trial Info
Start Date :
November 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05351905
Start Date
November 22 2022
End Date
April 30 2026
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4